Array BioPharma (ARRY) Reports Q2 Loss of $0.79
Tweet Send to a Friend
Array BioPharma Inc. (Nasdaq: ARRY) reports Q2 loss of $0.79, versus the analyst estimate of ($0.66). Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
